Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Utilization of Dimethyl Fumarate and Related Molecules for Treatment of Multiple Sclerosis, Cancer, and Other Diseases.
Dimethyl fumarate blocks pro-inflammatory cytokine production via inhibition of TLR induced M1 and K63 ubiquitin chain formation.
Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis.
Neuron-Microglia Interaction Induced Bi-directional Cytotoxicity Associated with Calpain Activation.
Preventing the BDNF and NGF loss involved in the effects of cornel iridoid glycoside on attenuation of experimental autoimmune encephalomyelitis in mice.
Neurogenic bowel dysfunction (NBD) translation and linguistic validation to classical Arabic.
Dyschromatopsia in Multiple Sclerosis Patients: A Marker of Subclinical Involvement?
Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk.
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.
Changes in the Expression of miR-34a and its Target Genes Following Spinal Cord Injury In Rats.
Olfactory dysfunction as a marker of multiple sclerosis progression.
Pathologic and Protective Roles for Microglial Subsets and Bone Marrow- and Blood-Derived Myeloid Cells in Central Nervous System Inflammation.
Perturbed cholesterol homeostasis in aging spinal cord.
Variations in multiple sclerosis practice within Europe - Is it time for a new treatment guideline?
Nonfatal PML in a patient with multiple sclerosis treated with dimethyl fumarate.
Multi-Parametric Non-Negative Matrix Factorization for Longitudinal Variations Detection in White Matter Fiber-Bundles.
Calcium Signalling Triggered by NAADP in T Cells Determines Cell Shape and Motility During Immune Synapse Formation.
Effect of Fingolimod-Treatment on Blood Lipid Profiles of Multiple Sclerosis Patients.
Evolving Concepts in Posterior Subthalamic Area Deep Brain Stimulation for Treatment of Tremor: Surgical Neuroanatomy and Practical Considerations.
5-Hydroxymethylcytosine Remodeling Precedes Lineage Specification during Differentiation of Human CD4(+) T Cells.
Neuroimmunology of a natural disaster.
Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome.
Microglia Ontology and Signaling.
Evidence of Hepatitis E virus breaking through the blood-brain barrier and replicating in the central nervous system.
Cognitive impairment in MS: rehabilitation approaches.
Pages
« first
‹ previous
…
768
769
770
771
772
773
774
775
776
…
next ›
last »